Considering that brain is a major site of expression for CCN3 and that calmyrin was detected in difuse and senile plaques, the physical interaction of CCN3 and calmyrin and resulting effects on calcium signaling, might also be of significance in the pathogenesis of Alzheimer's disease. The gene discussed is CCN3; the disease is early-onset autosomal dominant Alzheimer disease.